Invesco’s Cytosorbents Corp CTSO Stock Holding History

Invesco’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,909	Closed	-$44K	–	4060
2022 Q1	$44K	Sell	13,909 -324	-2%	-$1.16K	﹤0.01%	3939
2021 Q4	$60K	Sell	14,233 -412	-3%	-$2.31K	﹤0.01%	3961
2021 Q3	$119K	Buy	14,645 +3,601	+33%	+$29.3K	﹤0.01%	3906
2021 Q2	$83K	Sell	11,044 -4,533	-29%	-$38.2K	﹤0.01%	3917
2021 Q1	$136K	Buy	+15,577	New	+$148K	﹤0.01%	3726
2019 Q2	–	Sell	-27,819	Closed	-$211K	–	3731
2019 Q1	$211K	Sell	27,819 -4,291	-13%	-$33.4K	﹤0.01%	3611
2018 Q4	$259K	Sell	32,110 -189,787	-86%	-$1.88M	﹤0.01%	3494
2018 Q3	$2.86M	Buy	221,897 +190,969	+617%	+$2.39M	﹤0.01%	2514
2018 Q2	$353K	Buy	+30,928	New	+$293K	﹤0.01%	3541

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco's CTSO Position: Q2 2022 in Review

Invesco sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 13,909 shares — an estimated $44K sold.

Invesco first reported a position in CTSO in Q2 2018 and held it in 9 quarters. The position peaked at $2.86M in Q3 2018. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

Invesco reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
Invesco sold 13,909 Cytosorbents Corp shares in Q2 2022, an estimated $44K.
Invesco first reported a position in Cytosorbents Corp in Q2 2018 and held it in 9 quarters.
Invesco's Cytosorbents Corp position peaked at $2.86M in Q3 2018.
78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.